Participants:18–64 years · 65+ years
Substances:N2-(3-(2-(2H-1,2,3-Triazol-2-Yl)Propan-2-Yl)-1-Cyclopropyl-1H-Pyrazol-5-Yl)-N4-Ethyl-5-(Trifluoromethyl)Pyrimidine-2,4-Diamine

Contact Research Centre

Systemic lupus erythematosus

Not recruiting

Registered drug

Study on Ianalumab for Patients with Systemic Lupus Erythematosus

Registered drug

Italy

Participants:0–17 years · 18–64 years · 65+ years
Substances:Emtricitabine

Contact Research Centre

Clear cell papillary renal cell carcinoma

Not recruiting

Registered drugNo placebo

Study Comparing Savolitinib and Durvalumab with Sunitinib and Durvalumab for Patients with Advanced Papillary Renal Cell Carcinoma

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Durvalumab

Contact Research Centre

Colitis ulcerative

Not recruiting

Registered drugNo placebo

Study on Vedolizumab for Children with Moderate to Severe Ulcerative Colitis

Registered drugNo placebo

Italy

Participants:0–17 years
Substances:Prednisone

Contact Research Centre

Hormone receptor positive HER2 negative breast cancer

Not recruiting

Registered drugNo placebo

Study Comparing Datopotamab Deruxtecan to Chemotherapy in Patients with Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Capecitabine

Contact Research Centre

Asthma

Not recruiting

Registered drug

Study Comparing Depemokimab, Mepolizumab, and Benralizumab for Adults and Adolescents with Severe Eosinophilic Asthma

Registered drug

Italy

Participants:0–17 years · 18–64 years · 65+ years
Substances:Benralizumab

Contact Research Centre

Non-small cell lung cancer+4

Not recruiting

Registered drug

Study on the Effectiveness and Safety of Osimertinib for Patients with Stage IB-IIIA Non-Small Cell Lung Cancer After Tumor Removal

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Osimertinib

Contact Research Centre

Colorectal cancer metastatic

Not recruiting

Registered drugNo placebo

Study on Retreatment with Encorafenib and Cetuximab for Patients with BRAF V600E Mutated Metastatic Colorectal Cancer

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Cetuximab

Contact Research Centre

Eosinophilic oesophagitis

Not recruiting

Registered drug

Study on Tezepelumab for Symptom Relief in Patients Aged 12-80 with Eosinophilic Esophagitis

Registered drug

Italy

Participants:0–17 years · 18–64 years · 65+ years
Substances:Tezepelumab

Contact Research Centre

Study on Melanoma Treatment: Comparing Encorafenib and Binimetinib with Ipilimumab and Nivolumab for Patients with BRAF V600 Mutation

Not recruiting

Registered drugNo placebo

Study on Melanoma Treatment: Comparing Encorafenib and Binimetinib with Ipilimumab and Nivolumab for Patients with BRAF V600 Mutation

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Binimetinib

Contact Research Centre

Neoplasm malignant+1

Not recruiting

Registered drugNo placebo

Study of Entrectinib for Patients with Advanced or Metastatic Solid Tumors with Specific Gene Changes

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Entrectinib

Contact Research Centre

Find therapies in clinical trials near you – page 58

810 trials match your criteria

Gastrointestinal melanoma+7

Study of Encorafenib, Binimetinib, and Pembrolizumab for Patients with BRAF V600E/K Mutation-Positive Melanoma After Anti-PD-1 Therapy

Parkinson's disease

Study on the Effectiveness and Safety of BIIB122 for Patients with Parkinson's Disease

Systemic lupus erythematosus

Study on Ianalumab for Patients with Systemic Lupus Erythematosus

Clear cell papillary renal cell carcinoma

Study Comparing Savolitinib and Durvalumab with Sunitinib and Durvalumab for Patients with Advanced Papillary Renal Cell Carcinoma

Colitis ulcerative

Study on Vedolizumab for Children with Moderate to Severe Ulcerative Colitis

Hormone receptor positive HER2 negative breast cancer

Study Comparing Datopotamab Deruxtecan to Chemotherapy in Patients with Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

Asthma

Study Comparing Depemokimab, Mepolizumab, and Benralizumab for Adults and Adolescents with Severe Eosinophilic Asthma

Non-small cell lung cancer+4

Study on the Effectiveness and Safety of Osimertinib for Patients with Stage IB-IIIA Non-Small Cell Lung Cancer After Tumor Removal

Colorectal cancer metastatic

Study on Retreatment with Encorafenib and Cetuximab for Patients with BRAF V600E Mutated Metastatic Colorectal Cancer

Eosinophilic oesophagitis

Study on Tezepelumab for Symptom Relief in Patients Aged 12-80 with Eosinophilic Esophagitis

Study on Melanoma Treatment: Comparing Encorafenib and Binimetinib with Ipilimumab and Nivolumab for Patients with BRAF V600 Mutation

Study on Melanoma Treatment: Comparing Encorafenib and Binimetinib with Ipilimumab and Nivolumab for Patients with BRAF V600 Mutation

Neoplasm malignant+1

Study of Entrectinib for Patients with Advanced or Metastatic Solid Tumors with Specific Gene Changes

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.